BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 6958247)

  • 1. Developing new drugs for ovarian cancer: a challenging task in a changing reality.
    Canetta RM; Carter SK
    J Cancer Res Clin Oncol; 1984; 107(2):111-24. PubMed ID: 6371015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic renal cell carcinoma.
    Van Echo DA; Markus S; Aisner J; Wiernik PH
    Cancer Treat Rep; 1980; 64(8-9):1009-10. PubMed ID: 6893810
    [No Abstract]   [Full Text] [Related]  

  • 3. m-AMSA in epithelial carcinoma of the ovary. A Southwest Oncology Group study.
    Hilgers RD; Legha SS; Panettiere FJ; Alberts DS
    Am J Clin Oncol; 1983 Jun; 6(3):277-9. PubMed ID: 6687779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (m-AMSA) in patients with gastric adenocarcinoma.
    Sordillo PP; Magill GB; Gralla RJ; Kelsen DP
    Am J Clin Oncol; 1982 Jun; 5(3):273-5. PubMed ID: 6896259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with non-small cell lung cancer.
    Casper ES; Gralla RJ; Kelsen DP; Natale RB; Sordillo P; Houghton A
    Cancer Treat Rep; 1980; 64(2-3):345-7. PubMed ID: 6893294
    [No Abstract]   [Full Text] [Related]  

  • 6. M-AMSA in disseminated prostatic carcinoma: a phase II study.
    Drelichman A; Decker DA; Al-Sarraf M; Dhabuwala CB
    Cancer Treat Rep; 1982 Nov; 66(11):1993-4. PubMed ID: 6897206
    [No Abstract]   [Full Text] [Related]  

  • 7. Meta AMSA (m-AMSA) in patients with advanced ovarian carcinoma.
    Kearsley JH; Page JP; Levi JA; Woods RL; Tattersall MH; Fox RM; Coates AS
    Aust N Z J Obstet Gynaecol; 1982 May; 22(2):107-9. PubMed ID: 6958247
    [No Abstract]   [Full Text] [Related]  

  • 8. Amsacrine (AMSA)--a clinical review.
    Louie AC; Issell BF
    J Clin Oncol; 1985 Apr; 3(4):562-92. PubMed ID: 3884748
    [No Abstract]   [Full Text] [Related]  

  • 9. Amsacrine (m-AMSA): a new antineoplastic agent. Pharmacology, clinical activity and toxicity.
    Hornedo J; Van Echo DA
    Pharmacotherapy; 1985; 5(2):78-90. PubMed ID: 2582401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m-AMSA: a review of clinical data.
    Zittoun R
    Eur J Cancer Clin Oncol; 1985 Jun; 21(6):649-53. PubMed ID: 3894030
    [No Abstract]   [Full Text] [Related]  

  • 11. The human tumor cloning assay in cancer research and therapy: a review with clinical correlations.
    Hanauske AR; Hanauske U; Von Hoff DD
    Curr Probl Cancer; 1985 Dec; 9(12):1-66. PubMed ID: 2419036
    [No Abstract]   [Full Text] [Related]  

  • 12. The mechanism of action of mAMSA.
    Marshall B; Ralph RK
    Adv Cancer Res; 1985; 44():267-93. PubMed ID: 3898738
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.